Article History
Accepted: 8 August 2019
First Online: 9 September 2019
Competing interests
: M.Y.D. is listed as the inventor on a patent filed in 2003 for the use of an IL-1 receptor antagonist for the treatment of or prophylaxis for type 2 diabetes. C.A.D. and T.M.-P. declare no competing interests.